Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
- Evaluation of the efficacy of an immunosuppressive therapy added to a comprehensive
supportive therapy to induce a clinical remission in patients at risk for progressive
IgAN
- Investigation of differences between the treatments regarding the number of patients
loosing more than 15 ml/min of GFR.